Skip to main content
Sai-Ching Yeung, MD, Internal Medicine, Houston, TX

Sai-ChingJ.YeungMD

Internal Medicine Houston, TX

Professor

Dr. Yeung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yeung's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Unit 1468
    Houston, TX 77030
    Phone+1 713-745-9911

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1995 - 1997
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1991 - 1994
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineClass of 1991
  • University of Houston, College of Natural Sciences and Mathematics
    University of Houston, College of Natural Sciences and MathematicsPhD, Biology, 1988 - 1988
  • University of Houston, College of Natural Sciences and Mathematics
    University of Houston, College of Natural Sciences and MathematicsMS, Biology, 1985 - 1985
  • University of Houston, College of Pharmacy
    University of Houston, College of PharmacyBS, Pharmacy, Magna Cum Laude, 1983 - 1983

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1983 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Continental WHO’s WHO 2006
  • Fellow of American College of Physicians American Society of Internal Medicine, 2002
  • Strathmore’s WHO’s WHO 2001
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.  
    He, X., Tu, S-M., Zhou, Z.-G., Qu, C-J., Xue, Y-W., Guma, S., Lee, M. H., Yeung, S. C, Ann. Oncol
  • Pim-1 plays a pivotal role in hypoxia-induced chemoresistance.  
    Chen, J., Kobayashi, M., Darmanin, S., Qiao, Y., Gully, C., Zhao, R., Yeung, S. C., Lee, M. H, Oncogene
  • Serum protein profiles in myasthenia gravis.  
    Cheng, C., Wu, G., Yeung, S. C., Li, R., Bella, A. E., Pang, J., Zhong, F., Luo, H., Jin, Y., Pan, J, Ann. Thoracic Surg
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • The tumor suppressor 14-3-3sigma is a new regulator of cancer metabolism.
    Phan,L., Chou, P. C., Samudio, I., Velazquez-Torres, G., Parreno, K., Huang, Y., Tseng, C., Vu, T., Gully, C., Su, C. H., Wang, E., Chen, J., Choi, H.H., Fuentes-Matte..., MD Anderson Cancer Trainee Research Day Basic Science Research
  • The role of angiogenesis inhibition in the in vivo antineoplasticeffect of manumycin plus paclitaxel.
    Yeung, S. J. andXu, G, The People’s Republic of China
  • Antineoplastic effects of an aurora B kinase inhibitor against breast cancer.
    Yeung, S. J., Christopher Gully, J. A. Yeung, and M. H. Lee, EHRLICH II — World Conference on Magic Bullets, Celebrating the 100th Anniversary of the Nobel Prize Award to Paul Ehrlich, Nürnberg
  • Join now to see all

Lectures

  • Preclinical Studies of Chemotherapy for Anaplastic Thyroid Carcinoma Antineoplastic activity of combinations including combretastatin A4 phosphate in a mouse xenograft... 
    Department of Pathophysiology, Sun Yat-Sen Medical College, Sun Yat-Sen University, Guangzhou
  • Oncologic Emergencies: show and tell. 
    Zhong Shan Cancer Center, Sun Yat-Sen University, Guangzhou, the People’s Republic of China
  • TP53 is a novel substrate of Aurora B kinase. 
    Department of Pathophysiology, School of Medicine, Sun Yat-Sen University, Guangzhou. 2011
  • Join now to see all

Other

Authored Content

  • Graves DiseaseMarch 2018
  • VIPomaMarch 2017

Press Mentions

  • Cardiovascular Events After ICI Therapy “Common” in Lung Cancer
    Cardiovascular Events After ICI Therapy “Common” in Lung CancerSeptember 20th, 2023

Professional Memberships

Other Languages

  • Chinese (Mandarin), Chinese (Cantonese)